Clinical Trial Update: A Dose Response Evaluation of SLITone Ultra HDM Mix Immunotherapy [Phase 2]

View source ↗

Summary

Phase 2 dose-response evaluation of SLITone Ultra HDM Mix Immunotherapy for allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• SLITone Ultra HDM Mix Immunotherapy

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Allergic Rhinitis | Phase 2 | Status: COMPLETED